0001209191-24-002014.txt : 20240122
0001209191-24-002014.hdr.sgml : 20240122
20240122174823
ACCESSION NUMBER: 0001209191-24-002014
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240118
FILED AS OF DATE: 20240122
DATE AS OF CHANGE: 20240122
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cui Xiangmin
CENTRAL INDEX KEY: 0001487815
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37449
FILM NUMBER: 24550031
MAIL ADDRESS:
STREET 1: NO. 14 EAST HUSHAN ROAD
STREET 2: TAI'AN CITY
CITY: SHANDONG
STATE: F4
ZIP: 000000
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALPINE IMMUNE SCIENCES, INC.
CENTRAL INDEX KEY: 0001626199
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 208969493
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 188 EAST BLAINE ST., SUITE 200
CITY: SEATTLE
STATE: WA
ZIP: 98102
BUSINESS PHONE: 206-788-4545
MAIL ADDRESS:
STREET 1: 188 EAST BLAINE ST., SUITE 200
CITY: SEATTLE
STATE: WA
ZIP: 98102
FORMER COMPANY:
FORMER CONFORMED NAME: Nivalis Therapeutics, Inc.
DATE OF NAME CHANGE: 20150211
FORMER COMPANY:
FORMER CONFORMED NAME: N30 Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20141121
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-01-18
0
0001626199
ALPINE IMMUNE SCIENCES, INC.
ALPN
0001487815
Cui Xiangmin
C/O ALPINE IMMUNE SCIENCES, INC.
201 ELLIOT AVENUE WEST, SUITE 230
SEATTLE
WA
98119
1
0
1
0
0
Common Stock
2024-01-18
4
X
0
1234636
12.74
A
6582380
I
See Footnote
Common Stock
1735544
I
See Footnote
Warrant (right to buy)
12.74
2024-01-18
4
X
0
1234636
0.00
D
2019-01-18
2024-01-18
Common Stock
1234636
0
I
See Footnote
These securities are owned directly by Decheng Capital China Life Sciences USD Fund III, L.P. ("Fund III"). The Reporting Person is the manager of Decheng Capital Management III (Cayman), LLC, the general partner of Fund III. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein.
These securities are owned directly by Decheng Capital Global Healthcare Fund (Master), LP ("Healthcare"). The Reporting Person is the indirect managing member and ultimate beneficial owner of Decheng Capital Global Healthcare GP, LLC, the general partner of Healthcare. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein.
/s/ Xiangmin Cui
2024-01-22